Regulator to clarify HIV/AIDS drug recall

The Medicines and Healthcare products Regulatory Agency is writing to HIV specialists and patient organisations setting out an action plan following the recall of HIV/AIDS drug Viracept (nelfinavir) due to contamination.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here